Did he actually say that??
Printable View
When you have a superior product, disruptive technology, a first mover advantage, a product that offers a one third reduction in work up costs for insurers over cytology, and an experienced team on the ground in the US gearing up to go, all one needs to add is time, patience and a five year plan.
Yawn, stretch, wake me when their done, …….., see you all at $5.
Attachment 5948
Part of the five year plan was CMS coverage in early 2014. That's now apparently 2015. Maybe its not a five year plan anymore.
How many more hurdles are going to take a year longer than planned?
Comes down to the big shareholders in there, NG.
They were prepared to front up and fund PEB 2 years ago in preference to PEB being swallowed by a Roche or J&J - because they saw the potential.
If they think that PEB cannot make it alone, watch the investment bankers move in - that's how these things work.
But you didn't address it then?
Ok thanks.
TBH , the delay aside, confirmation that CMS approval is coming is good enough for me.
The whole health system over there is a bog